STITCHES Medicine - the Best of Medical Research
Olaparib trial reveals limited efficacy for DNA damage response mutations; overall response rate lags at just 6.1%. by Doroshow DB, Shapiro GI (...) Eder JP et 12 al. in Cancer #MedSky 👉 get more here 📖 read the article: https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.70332
STITCHES Medicine

Every day we'll send you quick, insightful updates on medicine, carefully selected from top journals and the best papers, in a daily 5-minute read.

STITCHES - the General Surgery newsletter
Mar 24 at 9:08amWeb